SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+18.28%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$224M
AUM Growth
+$224M
(+53%)
Cap. Flow
+$66.1M
Cap. Flow
% of AUM
29.51%
Top 10 Holdings %
Top 10 Hldgs %
58.98%
Holding
54
New
19
Increased
12
Reduced
8
Closed
12
Top Buys
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$25.9M |
| 2 |
McKesson
MCK
|
$11M |
| 3 |
Sanofi
SNY
|
$9.84M |
| 4 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$9.13M |
| 5 |
VSI
Vitamin Shoppe Inc.
VSI
|
$7.85M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$7.98M |
| 2 |
Cardinal Health
CAH
|
$7.29M |
| 3 |
Medtronic
MDT
|
$6.02M |
| 4 |
Amgen
AMGN
|
$5.23M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$5.22M |
Sector Composition
| 1 | Healthcare | 78.67% |
| 2 | Financials | 2.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $28.6M | 12.68% | 1,789,156 +208,699 | +13% | +$3.34M |
|
|
DYAX
2
DELISTED
DYAX CORPORATION
DYAX
| $25.9M | 11.45% | +687,600 | New | +$25.9M |
|
|
3
Sanofi
SNY
$121B
| $15.4M | 6.84% | 361,962 +230,691 | +176% | +$9.84M |
|
|
NEOS
4
DELISTED
Neos Therapeutics, Inc
NEOS
| $11.2M | 4.96% | 781,514 +114,785 | +17% | +$1.64M |
|
|
5
McKesson
MCK
$85.4B
| $11M | 4.89% | +56,000 | New | +$11M |
|
|
AAAP
6
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $9.13M | 4.04% | +291,877 | New | +$9.13M |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $8.64M | 3.82% | 644,617 -37,689 | -6% | -$505K |
|
|
VSI
8
DELISTED
Vitamin Shoppe Inc.
VSI
| $7.85M | 3.48% | +240,000 | New | +$7.85M |
|
9
Cigna
CI
$80.3B
| $7.15M | 3.17% | 48,855 +3,362 | +7% | +$492K |
|
|
DMK
10
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $7.12M | 3.15% | 1,318,630 +11,770 | +0.9% | +$63.6K |
|
|
CTIC
11
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $6.51M | 2.88% | +5,292,262 | New | +$6.51M |
|
|
ANTH
12
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $6.4M | 2.83% | 1,378,443 +522,371 | +61% | +$2.42M |
|
13
AbbVie
ABBV
$372B
| $6.15M | 2.72% | 103,809 +9,493 | +10% | +$562K |
|
|
STJ
14
DELISTED
St Jude Medical
STJ
| $5.73M | 2.54% | +92,800 | New | +$5.73M |
|
|
PFNX
15
DELISTED
Pfenex Inc.
PFNX
| $5.54M | 2.45% | 447,262 +191,959 | +75% | +$2.38M |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $5.48M | 2.43% | +50,700 | New | +$5.48M |
|
17
Zimmer Biomet
ZBH
$21B
| $5.43M | 2.4% | +52,912 | New | +$5.43M |
|
18
Ascendis Pharma
ASND
$11.8B
| $5.22M | 2.31% | 284,785 +15,000 | +6% | +$275K |
|
19
UnitedHealth
UNH
$281B
| $4.18M | 1.85% | 35,500 -20,484 | -37% | -$2.41M |
|
20
Bristol-Myers Squibb
BMY
$96B
| $3.71M | 1.64% | 53,862 -28,872 | -35% | -$1.99M |
|
|
NTUS
21
DELISTED
Natus Medical Inc
NTUS
| $3.39M | 1.5% | 70,500 +20,500 | +41% | +$985K |
|
|
FOMX
22
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.37M | 1.49% | 415,972 +79,686 | +24% | +$646K |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $3.32M | 1.47% | 117,257 +15,491 | +15% | +$439K |
|
24
Addus HomeCare
ADUS
$2.12B
| $2.92M | 1.29% | +125,526 | New | +$2.92M |
|
25
Merck
MRK
$210B
| $2.87M | 1.27% | +54,375 | New | +$2.87M |
|